Tafenoquine succinateProduct ingredient for Tafenoquine

Tafenoquine is an 8-aminoquinoline analogue of primaquine which varies only on the presence of a 5-phenoxy group.^1,3 It was discovered by the scientists at the Walter Reed Army Institute of Research in 1978 as a substitute for primaquine that would be more effective against relapsing vivax malaria.³ Tafenoquine was further developed collaboratively between GlaxoSmithKline and Medicines for Malaria Venture.² It was FDA approved on July 20, 2018.⁶